首页> 外文OA文献 >Formulation and evaluation of floating mucoadhesive alginate beads for targetingHelicobacter pylori
【2h】

Formulation and evaluation of floating mucoadhesive alginate beads for targetingHelicobacter pylori

机译:用于靶向幽门螺杆菌的漂浮粘膜粘附藻酸盐珠粒的配方和评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objectives: There are various obstacles in the eradication of Helicobacter.pylori (H. pylori) infections, including low antibiotic levels and poor accessibility of the drug at the site of the infection. This study describes the preparation and characterisation of novel floating-mucoadhesive alginate beads loaded with clarithromycin (CMN) for delivery to the gastric mucosa to improve the eradication of this micro-organism.\udMethods: Calcium alginate beads were prepared by ionotropic gelation. The formulation was modified through addition of oil and coating with chitosan in order to improve floating, mucoadhesion and modify drug release.\udKey findings: SEM confirmed the sphericity of the beads with X-ray microtomography (XμMT) showing the 3D structure of the beads with the layered internal structure of the bead and the even distribution of the drug within the bead. This formulation combined two gastro-retentive strategies and these formulations produced excellent in vitro floating, mucoadhesive and drug release characteristics. Enhanced stability of the beads in phosphate buffer raises a potential for the modified formulations to be targeted to regions of higher pH within the gastrointestinal tract with a higher pH. Drug release from these beads was sustained through an unstirred mucin layer simulating in vivo conditions under which the H. pylori resides in the gastric mucosa.\udConclusions: This novel formulation will ensure retention for a longer period in the stomach than conventional formulations and control drug release, ensuring high local drug concentrations, leading to improved eradication of the bacteria.
机译:目的:根除幽门螺杆菌(H. pylori)感染存在多种障碍,包括抗生素水平低和感染部位药物的可及性差。这项研究描述了载有克拉霉素(CMN)的新型漂浮粘膜粘附藻酸盐微珠的制备和表征,该微藻藻酸盐微珠可递送至胃粘膜以改善该微生物的根除。\ ud方法:通过离子凝胶法制备藻酸钙微珠。主要结果:SEM通过X射线显微断层扫描(XμMT)证实了微珠的3D结构,从而通过改善油脂的漂浮,粘膜粘附力和改善药物释放来修饰配方。珠子的分层内部结构以及药物在珠子中的均匀分布。该制剂结合了两种保持胃的策略,这些制剂具有出色的体外漂浮,粘膜粘附和药物释放特性。珠在磷酸盐缓冲液中增强的稳定性提高了将改性制剂靶向于胃肠道内具有较高pH的较高pH区域的潜力。这些药珠的释放是通过未搅拌的粘蛋白层持续进行的,该粘蛋白层模拟幽门螺杆菌在胃黏膜中的体内条件。释放,确保高局部药物浓度,从而改善细菌的根除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号